This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Kenneth L. Beers, MD
Altoona, Pa

JAMA. 1979;242(10):1031-1032.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

This is a report of a clinical failure with substituted tolbutamide. My letter is prompted by the potentially serious situation that was created when one of my diabetic patients permitted substitution without my knowledge of a refill prescription for a specific brand of tolbutamide.

Report of a Case.—

The patient was a 71-year-old woman whose diabetes had been stabilized for seven years with diet and a daily dosage of tolbutamide (Orinase), 500 mg four times a day. The patient's fasting and postprandial blood glucose levels were generally maintained within a range of 100 to 140 mg/dL, and no noteworthy clinical complications associated with blood glucose control had occurred during her relatively long history of diabetes mellitus.

During a routine visit to my office, the patient's blood glucose level was found to be 400 mg/dL, and she mentioned that she had not been feeling well. Careful questioning of . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?